FDA Inspection 818014 — Stason Pharmaceuticals, Inc.
The FDA completed an inspection of Stason Pharmaceuticals, Inc. on February 8, 2013 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 8, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Irvine, CA (United States)